Claire Veronica Broome (born August 24, 1949) is an American epidemiologist, specializing in public health surveillance and vaccine evaluation, who has contributed to the development and effective utilization of key vaccines against pathogens causing pneumonia and meningitis.
During this period, Dr. Broome served as a chairperson for the World Health Organization (WHO) Steering Committee for Encapsulated Bacteria, which was responsible for funding and implementing a research portfolio on vaccines needed to prevent bacterial meningitis and pneumonia in developing countries (part of the WHO Programme for Vaccine Development, a predecessor of the CVI and GAVI).
These systems use the same standards which have been endorsed for clinical Electronic Health records; the majority of states in the country are now implementing one or more NEDSS functions.
She also served as CDC's participant in national public private consortia to accelerate standards based Electronic Health Records.
[7][8] Notable accomplishments included development of a new method for observational measurement of the effectiveness of the pneumoccal polysaccharide vaccine (the "indirect cohort" or "Broome" method),[9] which has been used since then to assess serotype specific effectiveness, duration of effectiveness, and effectiveness in groups with underlying disease; designed observational and field trials to evaluate vaccine performance, including sequential case control studies to define duration of meningococcal polysaccharide vaccine effectiveness in Burkina Faso;[10] a cluster randomized trial of Group B meningococcal vaccine efficacy in Cuba; and Haemophilus influenzae type b conjugate vaccine impact on pneumonia in the Gambia; creation of funded population based active surveillance sites for 5 invasive bacterial pathogens (the forerunner of domestic Emerging Infections Programs); and demonstration that epidemic and sporadic listeriosis was a food-borne disease.